Personal information

Other IDs

SciProfiles: 1829698

Activities

Collapse all

Employment (1)

Karolinska University Hospital: Stockholm, SE

2016-03 to present | Resident (The Department of Oncology)
Employment
Source: Self-asserted source
Meis Omran

Education and qualifications (1)

Lund University: Lund, SE

2006 to 2011-06 | MD
Education
Source: Self-asserted source
Meis Omran

Works (6)

Limiting surveillance in individuals with the Palestinian TP53 p. R181C founder variant—is it too soon to draw conclusions?

JNCI: Journal of the National Cancer Institute
2025-02-06 | Journal article
DOI: 10.1093/jnci/djaf009
Contributors: Meis Omran; David Malkin
Source: check_circle
Crossref

Characterisation of heritable TP53-related cancer syndrome in Sweden—a nationwide study of genotype-phenotype correlations in 90 families

European Journal of Human Genetics
2025-01-05 | Journal article
DOI: 10.1038/s41431-024-01753-1
Contributors: Meis Omran; Yaxuan Liu; Alexander Sun Zhang; Anna Poluha; Marie Stenmark-Askmalm; Fredrik Persson; Anna-Lotta Hallbeck; Anna Rosén; Hafdis T. Helgadottir; Emma Tham et al.
Source: check_circle
Crossref

Whole‐body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer: Data from the Swedish TP53 Study

Cancer
2023-03-15 | Journal article
DOI: 10.1002/cncr.34631
Contributors: Meis Omran; Hemming Johansson; Claudia Lundgren; Gustav Silander; Marie Stenmark‐Askmalm; Niklas Loman; Annika Baan; Jamila Adra; Ekaterina Kuchinskaya; Lennart Blomqvist et al.
Source: check_circle
Crossref

Whole-Body MRI Surveillance—Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53)

Cancers
2022-01-13 | Journal article
DOI: 10.3390/cancers14020380
Contributors: Meis Omran; Emma Tham; Yvonne Brandberg; Håkan Ahlström; Claudia Lundgren; Ylva Paulsson-Karlsson; Ekaterina Kuchinskaya; Gustav Silander; Anna Rosén; Fredrik Persson et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53

Hereditary Cancer in Clinical Practice
2020-12 | Journal article
DOI: 10.1186/s13053-020-0133-5
Contributors: Meis Omran; Lennart Blomqvist; Yvonne Brandberg; Niklas Pal; Per Kogner; Anne Kinhult Ståhlbom; Emma Tham; Svetlana Bajalica-Lagercrantz
Source: check_circle
Crossref

ABC om farmakologisk symtomlindring vid livets slutskede

Läkartidningen
2017-02-03 | Journal article
Source: Self-asserted source
Meis Omran
How many people are using ORCID?